Kathryn J Collier
CIK 1737436 · last filed 2025-06-27
Kathryn J Collier is a corporate insider who has filed 17 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing, for RGLS, was dated Jun 27, 2025. Across all open-market trades the lifetime net is +$17.3K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
17
$17.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Regulus Therapeutics Inc. (RGLS) Delisted | Director | 0 | $8.16 | $0 | $17.3K | 17 | 2025-06-27 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-27 | Regulus Therapeutics Inc. (RGLS) Delisted | Disp (D) | −75,565 | $0 | EDGAR |
| 2025-06-18 | Regulus Therapeutics Inc. (RGLS) Delisted | Exer (M) | +6,325 | $60.1K | EDGAR |
| 2025-04-30 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | +62,500 | $0 | EDGAR |
| 2024-07-29 | Regulus Therapeutics Inc. (RGLS) Delisted | Buy (P) | +4,000 | $7.3K | EDGAR |
| 2024-05-21 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-14 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-13 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-15 | Regulus Therapeutics Inc. (RGLS) Delisted | Grant (A) | — | $0 | EDGAR |